Primary Record
ent-Aprepitant
- In stock
- 5,564 g
- Purity
- 98.2 %
- CAS
- 172822-29-6
Compound Identifiers & Properties
- CAS
- 172822-29-6
- PubChem CID
- 135934925
- SMILES
- C[C@@H](C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)O[C@H]2[C@H](N(CCO2)CC3=NNC(=O)N3)C4=CC=C(C=C4)F
- Canonical SMILES
- C[C@H](O[C@@H]1OCCN(Cc2n[nH]c(=O)[nH]2)[C@@H]1c1ccc(F)cc1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1
Names & Synonyms
- ent-Aprepitant
- Emend
- Aprepitant Impurity M
- Aprepitant Impurity 4
- UNII-CV944ASG28
- CV944ASG28
- 172822-29-6
- 1S,2S,3R Aprepitant
- RefChem:200785
- Aprepitant - MK-0869
- APREPITANT, (-)-
- Aprepitant Related Compound B
- Aprepitant related compound B [USP]
- DTXSID40571744
- ATALOFNDEOCMKK-KNMUDHKVSA-N
- C23H21F7N4O3
- Aprepitant related compound B (USP)
- MK-869
- MK0869
- ZINC59125344
- AKOS025149369
- ACN-047982
- FE22679
- APREPITANT RELATED COMPOUND B [USP-RS]
- J1.209.328D
- APREPITANT RELATED COMPOUND B (USP-RS)
- APREPITANT RELATED COMPOUND B [USP IMPURITY]
- A899423
- APREPITANT RELATED COMPOUND B (USP IMPURITY)
- L-754030
- 3-[[(2S,3R)-2-[(1S)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl]-1,4-dihydro-1,2,4-triazol-5-one
- 3H-1,2,4-Triazol-3-one, 5-(((2S,3R)-2-((1S)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)-4-morpholinyl)methyl)-1,2-dihydro-
- 5-(((2S,3R)-2-((1S)-1-(3,5-Bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)-4-morpholinyl)methyl)-1,2-dihydro-3H-1,2,4-triazol-3-one
- 3-(((2S,3R)-2-((S)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)morpholino)methyl)-1H-1,2,4-triazol-5(4H)-one
- 5-(((2S,3R)-2-((S)-1-(3,5-Bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)morpholino)methyl)-1,2-dihydro-3H-1,2,4-triazol-3-one
- [2S-[2|A(R*),3|A]]-5-[[2-[1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-3H-1,2,4-triazol-3-one
- [2S-[2a(R*),3a]]-5-[[2-[1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-d
- 3-[[(2S,3R)-2-[(S)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholino]methyl]-1H-1,2,4-triazol-5(4H)-one
- 3-[[(2S,3R)-2-[(S)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholino]methyl]-1H-1,2,4-triazol-5(4H)-one ((S,R,S)-Aprepitant)
- 3-[[(2S,3R)-2-[[(alphaS)-alpha-Methyl-3,5-bis(trifluoromethyl)benzyl]oxy]-3-(4-fluorophenyl)morpholine-4-yl]methyl]-1H-1,2,4-triazole-5(4H)-one
- 3-[[2beta-[(S)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3beta-(4-fluorophenyl)morpholine-4-yl]methyl]-1H-1,2,4-triazole-5(4H)-one
- 3-[2beta-[(S)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3beta-(4-fluorophenyl)morpholine-4-ylmethyl]-1H-1,2,4-triazole-5(4H)-one
- 3-{[(2S,3R)-2-[(1S)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl}-4,5-dihydro-1H-1,2,4-triazol-5-one
- 3H-1,2,4-Triazol-3-one, 5-[[(2S,3R)-2-[(1S)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-; ent-Aprepitant; Aprepitant Related Compound B (USP); 3-[[(2S,3R)-2-[(S)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholino]methyl]-1H-1,2,4-triazol-5(4H)-one; 3H-1,2,4-Triazol-3-one, 5-[[2-[1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-, [2S-[2alpha(R*),3alpha]]-; Aprepitant Related Compound B
- 5-[[(2S,3R)-2-[(1S)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-3H-1,2,4-triazol- 3-one
- 5-[[(2S,3R)-2-[(1S)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-3H-1,2,4-triazol-3-one
- 5-[[(2S,3R)-2-[(1S)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl]-1,2-dihydro-1,2,4-triazol-3-one
- 5-{[(2S,3R)-2-{(1S)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy}-3-(4-fluorophenyl)morpholin-4-yl]methyl}-1,2-dihydro-3H-1,2,4-triazol-3-one